1. Health technology

  2. •

    Medical specialties
Alcon AG

Alcon AG

56.28
EUR
-0.66
(-1.16%)
1.43EPS
45.97P/E
32.19BMarket Cap
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
13.74
13.53
14.38
14.87
12.36
15.43
16.39
16.13
18.19
16.71
17.2
Basic EPS, GAAP
-0.35
0.51
-0.46
-1.3
-0.96
0.7
0.63
1.66
1.87
1.57
1.32
Free Cash Flow per Basic Share
1.54
1.44
0.86
0.48
0.46
0.31
0.89
0.92
2.58
2.58
2.57
Dividend per Share
- -
- -
- -
- -
- -
0.1
0.19
0.2
0.24
0.27
- -
Book Value per Share
- -
45.89
45.52
38.23
34.04
35.84
37.1
35.17
39.53
- -
36.23
Tangible Book Value per Share
- -
5.17
6.15
0.33
1.48
2.95
2
4.5
7.37
- -
6.54
Basic Weighted Avg Shares
489
489
489
488
489
490
491
493
494
493
491
Sales/Revenue/Turnover
6,713
6,614
7,029
7,260
6,045
7,563
8,055
7,953
8,991
8,242
8,451
Operating Margin (%)
0.15
-1.13
-3.47
-2.49
-7.05
7
7.71
10.99
14.26
13.08
11.13
Depreciation Expense
1,312
1,271
1,594
1,378
1,436
1,112
1,038
1,027
1,114
1,058
1,070
Net Income, GAAP
-173
249
-223
-634
-470
343
310
819
923
777
651
Effective Tax Rate (%)
- -
- -
- -
- -
- -
10.05
27.65
- -
18.95
15.52
16.94
Profit Margin (%)
-2.58
3.77
-3.17
-8.74
-7.77
4.54
3.84
10.3
10.27
9.42
7.7
Working Capital
- -
1,469
1,480
1,872
2,414
2,658
2,269
2,733
3,657
2,694
2,887
LT Debt
- -
82
87
3,382
3,772
3,927
4,528
4,215
389
340
3,677
Total Equity
- -
22,424
22,245
18,666
16,651
17,565
18,183
17,347
19,552
- -
17,671
Return on Invested Capital (%)
- -
- -
- -
- -
- -
2.23
2
- -
4.95
- -
3.38
Return on Capital (%)
- -
- -
- -
- -
- -
2.09
1.79
- -
5.1
- -
3.43
Return on Common Equity (%)
- -
- -
-1
-3.1
-2.66
2
1.73
4.61
5.01
- -
3.51

Capital Structure

CHF

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
515
- -
517
LT Borrowings
3,311
- -
3,319
LT Finance Leases
340
340
358
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
491
487
488
Market Capitalization
28,889
30,819
29,707

Working Capital

CHF

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
5,037
5,110
5,286
Cash, Cash Equivalents & STI
1,191
- -
1,325
Accounts Receivable, Net
1,518
- -
1,582
Inventories
1,935
1,895
1,947
Total Current Liabilities
2,378
2,416
2,398
Payables & Accruals
868
- -
900
ST Debt
515
- -
517
Deferred Revenue
- -
67
- -

Growth Rates

CHF

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
68.45%
-0.18%
Net Income, GAAP
- -
-4.26%
-15.91%
Sales/Revenue/Turnover
- -
7.01%
-8.34%
Total Cash Common Dividend
- -
- -
11.53%

Quarterly Revenue

CHF

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,216
2,242
2,074
2,270
8,991
2025
2,186
2,058
2,079
2,154
8,242
2026
2,161
- -
- -
- -
- -

Quarterly Earnings Per Share

CHF

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.45
0.41
0.45
0.52
1.87
2025
0.62
0.28
0.38
0.35
1.57
2026
0.31
- -
- -
- -
- -

Quarterly Dividends Per Share

CHF

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.24
2025
- -
- -
- -
- -
0.27
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
Address
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business